Brokerages Set Encompass Health Co. (NYSE:EHC) Target Price at $107.11

Encompass Health Co. (NYSE:EHC) has been assigned a consensus recommendation of “Buy” from the eleven analysts that are currently covering the stock, MarketBeat reports. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $107.11.

Several equities research analysts have weighed in on the company. Barclays upped their price target on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. UBS Group raised their target price on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. KeyCorp boosted their price target on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Royal Bank of Canada raised their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Finally, Truist Financial reiterated a “buy” rating and set a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th.

Institutional Investors Weigh In On Encompass Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in EHC. Panagora Asset Management Inc. purchased a new stake in Encompass Health in the 2nd quarter valued at $400,000. Commonwealth Equity Services LLC raised its holdings in shares of Encompass Health by 1.3% in the second quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company’s stock valued at $845,000 after buying an additional 123 shares during the last quarter. Drive Wealth Management LLC acquired a new stake in shares of Encompass Health during the second quarter worth about $209,000. Natixis Advisors LLC grew its holdings in shares of Encompass Health by 15.3% during the second quarter. Natixis Advisors LLC now owns 94,002 shares of the company’s stock worth $8,064,000 after buying an additional 12,495 shares during the last quarter. Finally, CIBC Asset Management Inc raised its stake in Encompass Health by 14.4% during the 2nd quarter. CIBC Asset Management Inc now owns 2,857 shares of the company’s stock valued at $245,000 after acquiring an additional 360 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Trading Up 0.0 %

NYSE EHC opened at $91.19 on Tuesday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a market cap of $9.19 billion, a price-to-earnings ratio of 22.03, a PEG ratio of 1.30 and a beta of 0.89. The firm has a 50 day simple moving average of $98.86 and a 200-day simple moving average of $93.58. Encompass Health has a one year low of $67.12 and a one year high of $104.55.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter last year, the company posted $0.86 EPS. The firm’s revenue was up 11.9% compared to the same quarter last year. Equities research analysts anticipate that Encompass Health will post 4.29 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.75%. Encompass Health’s dividend payout ratio is presently 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.